Enlivex Therapeutics Ltd

NASDAQ:ENLV   9:57:08 AM EDT
9.46
-0.25 (-2.58%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Enlivex Therapeutics Ltd Stock, NASDAQ:ENLV

14 Einstein Street, 14 Einstein Street, Nes-Ziona, Tel Aviv 7403618
Israel
Phone: +972.2.6708072
Number of Employees: 50

Description

Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn's disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company was founded on January 22, 2012 and is headquartered in Nes-Ziona, Israel.